-
I’m a cancer surgeon - when I got breast cancer, I told my husband to divorce me
30 Jan 2025 13:03 GMT
… felt immense guilt for how breast cancer affected her marriage and her … when I was recovering from chemotherapy, and he had to leave … ’t any easier. I had chemotherapy at first, which left me … . I felt guilty for what breast cancer had brought to my marriage …
-
Wynne Evans made 'repulsive' joke about my bald head, says breast cancer survivor who lost her hair during chemotherapy
30 Jan 2025 10:47 GMT
A breast cancer survivor who lost her hair during chemotherapy has revealed how underfire … appearance
Breast cancer survivor Ms Jones, who lost her hair during chemotherapy, claimed … unwell and was going through chemotherapy
Cath (seen right), from Caerphilly …
-
Ginger-Derived Exosome-Like Nanoparticles Loaded With Indocyanine Green Enhances Phototherapy Efficacy for Breast Cancer
30 Jan 2025 07:20 GMT
… mediated breast tumor therapy effect by directly inhibiting breast tumor … facilitated photo-mediated breast tumor therapy. Furthermore, the … modalities, such as chemotherapy and immunotherapy. Moreover, … with basal-like breast cancer cell invasion. J …
-
FDA expands Enhertu approval to include HER2-ultralow breast cancer patients
29 Jan 2025 17:35 GMT
… approved for HER2-low breast cancer. Dave Fredrickson, … (IHC). Traditionally, breast cancers were categorised as either … for HER2-low breast cancer, marking the third … breast cancer in patients previously treated with endocrine-based therapy and chemotherapy …
-
Treatment Boosts Cure Rate for Most Common Form of Breast Cancer in Trial
29 Jan 2025 11:26 GMT
… of all breast cancers. These patients receive chemotherapy to shrink … most common type of breast cancer.”
Subscribe to Technology … million cases of breast cancer diagnosed worldwide in … and chemotherapy in early estrogen receptor-positive breast cancer: a …
-
US FDA approves AstraZeneca & Daiichi Sankyo’s Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies
29 Jan 2025 04:34 GMT
… HER2-ultralow chemotherapy-naïve breast cancer indication. The … breast cancer subtype, accounting for approximately 70% of all breast cancers … new breast cancer settings.
In HR-positive breast cancer, … negative breast cancer, an aggressive form of breast cancer, …
-
Is menopause putting you at risk for breast cancer? Here’s what you need to know
29 Jan 2025 03:16 GMT
…
How Common Is Breast Cancer After Menopause?
Breast cancer is more common … successful treatment.
What Causes Breast Cancer After Menopause?
Several factors … for Breast Cancer After Menopause
Treatment options include surgery, hormone therapy, chemotherapy, …
-
40% of chemotherapy patients have persistent nerve pain: 4 notes
29 Jan 2025 18:38 GMT
… and predictors of chronic painful [chemotherapy induced peripheral neuropathy] is critical … findings emphasize that chronic painful [chemotherapy induced peripheral neuropathy] represents a … treatment for bowel, lung and breast cancer had the highest number of …
-
Enhertu Approved in the US for Metastatic Breast Cancer
28 Jan 2025 23:27 GMT
… HER2-ultralow metastatic breast cancer following endocrine therapy.” … HER2-expressing metastatic breast cancer. The approval also … in how certain breast cancers can be treated.” … and HER2-ultralow chemotherapy-naïve breast cancer indication. The milestone …
-
Inavolisib Combo Meets OS End Point in PIK3CA+ Metastatic Breast Cancer
28 Jan 2025 23:28 GMT
… resistant, locally advanced or metastatic breast cancer, according to a press release … , locally advanced or metastatic breast cancer after recurrence on or after … therapy.
Previous neoadjuvant or adjuvant chemotherapy and endocrine therapy were observed …